Coming soon: The Life Sciences Industry Report 2025 – insights and predictions you won’t want to miss

How will AI continue to transform drug development? What’s next for cell and gene therapy? Who will take the crown in the “miracle” GLP-1 space after a year of shortages and controversy?

As life sciences innovation accelerates and regulatory landscapes evolve, these questions demand answers – and actionable insights.

This December, pharmaphorum answers the call with our Life Sciences Industry Report: Trends & Predictions 2025. Packed with thought leadership articles and expert analysis, this report promises a detailed examination of pivotal issues that will define 2025.

The pharmaphorum editorial team, alongside a powerhouse of industry experts, will explore crucial topics, including key therapeutic areas to watch, advancements in AI and digital health, and the impact of shifting political and regulatory landscapes.

What to expect: Setting the scene for 2025

Our analysis begins with a topline review of 2024’s defining moments – including market performance, breakthrough drug launches, and pivotal regulatory activity – creating a foundation for understanding what’s next.

Building on this market intelligence, industry leaders will take the reins to illuminate the technological and therapeutic advances shaping tomorrow. Through detailed analyses of topics such as cancer immunotherapy breakthroughs, personalised medicine innovations, and AI in drug discovery and development, we connect today’s trends to tomorrow’s opportunities.

This dual perspective of market overview paired with expert insights, provides both the broad context and specialised knowledge needed to navigate 2025’s landscape.

How to get involved

The Life Sciences Industry Report: Trends & Predictions 2025 is built for those who are serious about growth, innovation, and impact. Whether you’re involved in R&D, market access, regulatory affairs, or digital health, this report will be an invaluable resource for identifying key trends and actionable insights.

With pharmaphorum’s most extensive promotional campaign to date, it’s set to reach professionals who need to stay ahead of industry shifts and strategic developments. This report was born out of comprehensive reader research, revealing an increasing appetite for this type of publication among pharma, biotech, and healthcare experts ready to leverage new insights and lead with forward-thinking strategies.

There is still time to get involved. If you are interested in becoming a defining voice in the future of Life Sciences progress, check out the media kit, or contact matthew.brookes@pharmaphorum.com, and get ready to set your course for a year of informed and strategic decision-making.